About Us

Headquartered in Ponte Vedra Beach, Florida, Treace Medical Concepts, Inc. is a foot and ankle company focused on strategic product development activities that improve surgical efficiencies and patient outcomes, while reducing healthcare costs.


Mission Statement

We are a medical device company that specializes in the design, manufacture, and marketing of device and/or biologic solutions for foot and ankle physicians. We are committed to operating our business with the highest standards of ethical conduct. We will exceed our customers’ expectations through an innovation-driven, high-velocity approach to solving treatment and surgical problems. With our products and services, our mission is to assist foot and ankle physicians in improving patient outcomes and reducing healthcare costs, while providing a rewarding experience for our employees and an exceptional return for our shareholders.


Our Core Values and Beliefs

We believe a strong culture of integrity and compliance is critically important to building a world class business. Our Shared Values support our commitment to this philosophy.

  • Always do the right thing for our customers, employees, and shareholders.
    Don’t take a position that favors one over the other.
  • Have a passion for your job and enlist the willing cooperation of others.
  • Have a sense of urgency to win every day.
  • Don’t run out of cash – no matter what.
  • No surprises – tell the bad news first, not last.
  • Create true value – not through paper or gimmicks.
  • Maintain an employee friendly environment.
  • Only surround yourself with high-performers.
    Make it a challenge to get on board and difficult to leave.
  • Those buy from those who teach.
  • Be careful – a little success can create a lot of overhead.
  • Have fun with your job!


Compliance

To support its commitment to a strong culture of integrity and compliance, Treace Medical Concepts, Inc. (“TMC” or the “Company”) endorses and abides by the Advanced Medical Technology Association Code of Ethics on Interactions with Healthcare Professionals (“AdvaMed Code”) designed to promote ethical and appropriate interactions.

California Health and Safety Code §§ 119400–119402 Declaration

The Company declares that:

  1. It is in the business of designing, manufacturing and selling orthopaedic medical devices. As a medical device manufacturer, it endorses and abides by the AdvaMed Code. In addition, in accordance with the California Marketing Practices Act (California Health and Safety Code §§ 119400-119402, or the “California Statute”), TMC has further adopted a compliance program incorporating provisions of the AdvaMed Code.
  2. To the best of our knowledge, TMC is in compliance with the AdvaMed Code and the requirements of the California Statute as of January 1, 2017. TMC will evaluate and update our compliance program, as necessary and appropriate.
If you would like to receive a printed version of this Annual Declaration of Compliance and/or the AdvaMed Code, you may contact Kirk Brennan at (904) 373-5940.


Our Team

John T. Treace, CEO, Founder and Board Member

Mr. Treace founded Treace Medical Concepts, Inc. in January, 2014. Mr. Treace has over 22 years of expertise in medical device Marketing, Sales, and General Management. Mr. Treace is the former Senior Vice President of US Sales and Global Marketing for Wright Medical, Inc. (WMGI). During a 12 year tenure with Wright, Mr. Treace served in a number of senior management roles including V.P. of Marketing and G.M. - Biologics and Extremities. Prior to Wright, Mr. Treace was Director of Marketing for Medtronic Xomed (MDT) and Advertising & Marketing Director for start-up company, TreBay Medical Corp. Mr. Treace also served on the Board of ENTrigue Surgical, which was acquired by Arthrocare Corporation in July, 2013.

Kirk A. Brennan, Vice President, Corporate Controller

Kirk has 18 years of experience as an accounting professional in both public accounting and private industry. Prior to joining Treace Medical Concepts, Inc. he spent twelve years in medical device as divisional controller within Biomet Inc.’s craniomaxillofacial business unit in Jacksonville, Florida . Prior to his experience in the medical device sector Kirk worked in public accounting for a regional CPA firm based in Jacksonville. He also worked in various finance roles at the Corporate headquarters of Armor Holdings, a manufacturing company located in Jacksonville. Kirk is a Certified Public Accountant and obtained his Bachelors of Business Administration (accounting) from the University of North Florida and a Masters of Business Administration degree from Jacksonville University. Mr. Brennan is a board member for the Jacksonville Speech and Hearing Center and a member of Jacksonville University’s alumni board of governors.

Joe W. Ferguson, Chief Operating Officer

Mr. Ferguson has spent the last 20 years in medical device development spanning foot and ankle, extremities, trauma, large joint reconstruction, and spine. Most recently, Mr. Ferguson served as General Manager of the Florida Co-Innovation group of IMDS after having spent 4 years dedicated to foot and ankle specific R&D with Wright Medical, Inc. (WMGI). Mr. Ferguson has held positions with a variety of responsibilities including R&D, Quality, Operations, Intellectual Property and Regulatory for companies such as Smith & Nephew (SNN), Wright Medical, Inc., DePuy a Johnson & Johnson company (JNJ), Spinal Dynamics (acquired by Medtronic), Medtronic and IMDS. Mr. Ferguson also has 8 issued US patents and 23 patents pending.

Dipak Rajhansa, Chief Sales Officer

Mr. Rajhansa has over 25 years of progressive sales and marketing leadership experience; his past 15 years focused on commercializing disruptive technologies in the extremity orthopaedic market. From 2002 to mid-2017 he held the position of Senior Vice President of Sales and Marketing for Skeletal Dynamics, an innovative leader in the extremity market. Prior to this he held senior commercial positions with companies such as Hand Innovations (acquired by J&J Depuy in 2006), Orthosurgical Implants, Ortheon Medical, and U.S. Surgical Corporation (acquired by Tyco in 1998). Mr. Rajhansa holds a B.A. in Political Science from Washington University and an MBA from New York University.

Jaime A. Frias, Vice President, General Counsel, Secretary and Chief Compliance Officer

Mr. Frias has over 30 years of legal and compliance experience primarily in the medical device market. He began his collaboration with the Company in 2014 as legal counsel and corporate secretary through his firm, Frias Legal PA. Mr. Frias is the former Vice President, Chief Legal Counsel for the Surgical Technologies division of Medtronic, Inc. (MDT). During a 15-year tenure with Medtronic he was responsible for all legal and compliance matters for the MDT Surgical Technologies division as well as for the MDT Latin America division from 2000 to 2005. Prior to joining MDT, he served as in-house counsel for Xomed Surgical Products, Inc. from 1998 until the acquisition of Xomed by Medtronic (MDT) in 1999. From 1991 to 1998 Mr. Frias was in private practice in Jacksonville, Florida with the firms of Mahoney, Adams & Criser PA (becoming a shareholder in 1996) and McGuireWoods LLP. Prior to that, from 1988 to 1991, he was an associate with the New York offices of Baker & McKenzie, focusing primarily on securities, mergers and acquisitions and international transactions, and participated in the Baker & McKenzie International Clerkship Program in New York during the summer of 1986 and Madrid, Spain during the summer of 1987. He received his JD from The University of Michigan Law School in 1988 and holds a Bachelor of Music with high honors from the University of Florida.

James T. Treace, Chairman of the Board

James T. Treace is the Founder and President of J&A Group, LLC, a privately funded medical device investment and consulting company based in Jacksonville, Florida. Mr. Treace is the former President of Medtronic Xomed (MDT). Prior to its acquisition by Medtronic, Inc., in November 1999, Mr. Treace served as CEO, President and Chairman of the Board of Xomed Surgical Products, Inc. Additionally, he held CEO positions at TreBay Medical Corp., a private orthopaedic and microsurgical device company he co-founded; Concept, Inc., a leader in the arthroscopy device market, now known as Conmed Linvatec (CNMD); and Executive Vice President of Richards Medical, now known as Smith & Nephew (SNN). Former board positions include; Chairman of the Board of Kyphon, Inc. (now known as Medtronic Spine), Wright Medical, Inc. (WMGI), American Medical Systems, Inc. , now part of Endo Health Solutions, Inc. (ENDP) and Keystone Dental, Inc., a privately held dental implant company.

F. Barry Bays, Board Member

Mr. Bays is the former CEO & President and Chairman of the Board of Wright Medical, Inc. (WMGI) from 2000 to 2008. He was Chief Operating Officer of Xomed Surgical Products, Inc. prior to the acquisition by Medtronic, Inc. (MDT) and TreBay Medical Corp., a private orthopedic and microsurgical device company he co-founded. Additionally, he was the Chief Operating Officer of Concept, Inc., a leader in the arthroscopy device market - currently Conmed Linvatec (CNMD) - and VP of R&D of Richards Medical now known as Smith & Nephew (SNN).

Richard W. Mott, Board Member

Mr. Mott is currently Principal of Walkabout Consulting LLC, a management consulting and private equity firm, as well as Director/Owner of VFD Technologies. He currently consults for Warburg Pincus as an Executive in Residence, and Bio2 Technologies. In addition, he served as President, CEO and Director of Kyphon Inc., a NASDAQ-listed global medical device company through its acquisition by Medtronic, Inc. in late 2007. Prior to Kyphon, he was Chief Operating Officer at Wilson Greatbatch Technologies, Inc. and had executive operating roles within the Bristol-Myers Squibb Company. Current Board positions include Executive Chairman of MicroCHIPS, Inc., Chairman of Silk Road Medical, and Board member of Relievant Medsystems. Additionally, he is the previous recipient of the Ernst & Young Entrepreneur of the Year Award, the Frost & Sullivan Technology Leadership of the Year Award, and the Phoenix Lifetime Achievement Award. He holds a B.S. in Ceramic Engineering from Alfred University, and is a Graduate of Harvard University's Advanced Management Program.

John R. Treace, Board Member

John R. Treace is the President and Founder of JR Treace & Associates, a sales and marketing consulting firm in Jacksonville, Florida. Previously, Mr. Treace was Executive Vice President of North American Sales at Wright Medical, Inc (WMGI); Vice President of Sales at Medtronic Xomed (MDT); Vice President of Sales and Marketing of TreBay Medical Corp.; President of JR Treace & Associates, a medical device distribution company; and Vice President of Sales and Marketing of Richards Medical now known as Smith & Nephew (SNN). He is the author of Amazon’s top seller, Nuts & Bolts of Sales Management, How to Build a High Velocity Sales Organization, a monthly column contributor for Inc. Magazine, and a member of the National Speaker’s Association.

Thomas E. Timbie, Treasurer and Board Member

Thomas E. Timbie is the President of Timbie & Company, LLC, a financial and management consulting firm he founded in 2000. Mr. Timbie has over 30 years of financial experience primarily in the medical device market. During 2005, as the interim Chief Financial Officer of ev3 Inc., now part of Covidien (COV), Mr. Timbie helped lead ev3 through their initial public offering. He was also the CFO of Xomed Surgical Products, Inc. during their initial public offering in 1996 continuing in that role until the Company was acquired by Medtronic, Inc. (MDT) in 1999. Prior to Xomed, Mr. Timbie was the CFO of TreBay Medical Corp., a private orthopaedic and microsurgical device company and the Director of Accounting at Concept Inc., a leader in the arthroscopy device market, now known as Conmed Linvatec (CNMD). Mr. Timbie has also served as a board member and audit committee chairman of several public and private medical device companies including Wright Medical, Inc. (WMGI), ev3 Inc. acquired by Covidien (COV) in 2010, Acclarent, Inc., acquired by Johnson & Johnson (JNJ) in 2010 and American Medical Systems, Inc. acquired by Endo Pharmaceuticals (ENDP) in 2011. Mr. Timbie is also a former board member and audit committee chairman of two health care services companies; LaVie Care Centers and RegionalCare Hospital Partners.


Surgeon Advisors

Paul Dayton, DPM, MS, FACFAS

Dr. Dayton is currently the Director of Podiatric Medicine & Surgery Residency for UnityPoint Health, Trinity Regional Medical Center. His practice focus is traumatic and reconstructive surgery of the foot and ankle. Dr. Dayton is assistant professor at the college of Podiatric medicine and Surgery at Des Moines University. Dr. Dayton has co-authored numerous peer reviewed manuscripts and book chapters and has presented many national and international lectures during his 20 years of practice. He currently serves as Section Editor for the Journal of Foot and Ankle Surgery and serves on numerous educational and administrative boards.

Daniel J. Hatch, DPM, FACFAS

Dr. Daniel J. Hatch is a fellow and past president of the American College of Foot and Ankle Surgery. He is a section editor in reconstructive rear foot and ankle surgery for the Journal of Foot and Ankle Surgery. He has published articles in foot and ankle surgery and has lectured and conducted surgical workshops nationally. He is a surgical director of the North Colorado Podiatric Surgical Residency program. Dr. Hatch is board certified in foot and ankle surgery. He is on the advisory board for the International Foot and Ankle Foundation. He practices in Greeley, Colorado.

Robert D. Santrock, MD

Dr. Robert D. Santrock is the chief of Foot and Ankle Surgery at West Virginia University School of Medicine in Morgantown, West Virginia. A West Virginia native who returned to his Alma Matter to serve as a full-time professor of orthopaedic surgery, his passion is in the education of students, residents, and fellows. He is part of a major university program at a Level 1 Trauma center, and participates as part of the orthopaedic trauma team. Dr. Santrock is also committed to the collegiate athletics at WVU. Dr. Santrock’s special interests are in the treatment of post-traumatic arthritis and deformity of the foot and ankle, as well as in the treatment of diabetic foot disorders. Other research interests include the biomechanics of surgical materials, as well as ortho-biologic augmentation. Dr. Santrock attended WVU for his undergraduate, medical, and residency training before going on to fellowship training at The Orthopedic Foot and Ankle Center in Columbus, Ohio and Ohio State University under Thomas Lee, MD and Gregory Berlet, MD.

W. Bret Smith, DO

Bret Smith, DO, MS is the Director of the Foot and Ankle Division of the Moore Center of Orthopedics. He received his Doctorate of Osteopathic Medicine from The Philadelphia College of Osteopathic Medicine and performed his internship and orthopaedic residency at Doctors and Grant Hospitals in Columbus, Ohio. He subsequently completed his fellowship in orthopaedic foot and ankle surgery at the Orthopedic Foot and Ankle Center in Columbus, Ohio during which time he also served as an adjunct professor at the Ohio State University. Dr. Smith is board certified in orthopaedic surgery by the American Osteopathic Board of Orthopedic Surgeons and currently serves as a member of the education committee of the American Orthopaedic Foot and Ankle Society. He is the recent past-President of the Foot and Ankle Section of the American Osteopathic Academy of Orthopedics and has published numerous articles and textbook chapters related to his area of specialty. Dr. Smith also serves on several national speakers boards helping to educate other foot and ankle surgeons in the most advanced developments in his field.

Lowell Weil Jr., DPM, MBA

Dr. Weil, Jr., is the President and Fellowship Director of the Weil Foot & Ankle Institute. He is the Editor of Foot and Ankle Specialist the only combined orthopedic and podiatric peer reviewed journal in the world. He is a Partner of Foot & Ankle Business Innovations (FABI).He has authored over 50 publications and 10 book chapters. He is known as a surgical innovator and has IP on many devices currently used in foot and ankle surgery. He has lectured in 27 States and 14 countries.